Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-12-12

FDA Approved: FESOTERODINE FUMARATE — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for fesoterodine fumarate submitted by Camber Pharmaceuticals, Inc. under ANDA 204792. The action approves the supplemen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fesoterodine fumarate (fesoterodine fumarate)

Snippet

SUPPL AP for FESOTERODINE FUMARATE (FESOTERODINE FUMARATE)